SEC Form 4 · accession 0001209191-17-017709
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles J Homcy
Director
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2017 | M | 25,000 | $5.00 | A | 25,000 | D | |
| Common StockF2,F1 | Mar 1, 2017 | S | 25,000 | $37.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.00 | Mar 1, 2017 | M | 25,000 | D | Sep 20, 2007 | Sep 20, 2017 | Common Stock | 25,000 | 170,803 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2017.
- F2These shares were sold in a single transaction at a price of $37.50.